Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX003142 tablets in renal edema patients with poor response to conventional diuretics
CTR20253867Phase 2Active
- Sponsor
- Zhejiang Hangyu Pharmaceutical
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX003142 in renal edema, sponsored by Zhejiang Hangyu Pharmaceutical. Started Oct 2025; status: active.
02
Drugs
JMKX003142
03
Conditions
renal edema
Beyond the preview
Go deeper on CTR20253867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253867.